Polymorphic ventricular tachycardia induced by programmed stimulation: Response to procainamide  by Buxton, Alfred E. et al.
Polymorphic Ventricular Tachycardia Induced by Programmed 
Stimulation: Response to Procainamide 
ALFRED E. BUXTON, MD, FACC, MARK E. JOSEPHSON, MD, FAX, 
FRANCIS E. MARCHLINSKI, MD, FACC, JOHN M. MILLER, MD, FACC 
Philadelphia, Pennsylvania 
objectiws. Thk study w&v dfslgwd to evalurk the euect8 or 
pmcsiodde on pdymorphk veatrkular kchywdk tnduced by 
pnqwmoed sttmtitton and to cmrelak tbc req.xwa v&h beart 
d&ease. kft ventvteular eodocavdkl acttvattw sbn~ttics and 
Resulls. We evaluated 19 consecutive patknts ondorgdo~ 
cltoknt eleebopbysiologk studks!, in whom pdymorpbk vearic. 
of anttthythmk dro@. adminisbstiott, 
u&form mowmwpbk ventrtculav tacbyardta was tnduced ia l4 
patteots (Group i), tnductUe pa-k verdrtculu tncbycav- 
din per&ted In Xl prtkotv (Group 2) and 00 ventrtcotav t&y- 
cavdia could be induced in the rem&tog 25 patients (Gmop 3). 
p&ok (p =0X+3). Left veotrkukr aneurysm were aka found 
more frquadly (46%) in the pakats developtng uniform vm 
hladlrtacbycud~sflrr~thaoiaettberGmup2w 
Gmup 3 (13% sad 0% repecttvety, p < o.Gw. 
. h aucb patknts. 
(I Am Cdl CmW 1993$1.96-U) 
Polymorphic ventrice:Lr tachycardia is frequently induced 
by programmed ventricular stimulation. In some persons, 
such as subjects without slroctural heart disease and patients 
with recent myocardial infarction or syncope, induced poly- 
morphic ventricular tachycardia does not appear to be 
associated with an adverse prognosis (l-5). However, in 
other groups, such as patients rwscitated from cardiac 
arrest or with spontaneous sustained ventricular tacbycar- 
dia, the induced arrhythmia may be clinically rclcxmt (6-S). 
Horowitz et al. (6) reported in 1981 that some patients with 
inducible polymorphic ventricular tachycardia developed 
uniform ventricular tachywdia when programmed stimuli- 
tion was repeated after administration of type IA anti- 
arrhythmic drugs. They sueeested that this response was 
chamcteristic of tachycardias due to reentry and that in such 
cases, polymorphic tachycavdia was not an artifact of pro- 
grammed stimulation. 
The purpose of the present study was to evaluate system- 
atically the effects of procaioamide (as a prototypical typo 
1A atttiarrhytbmic agent) on polymorphic vsntricolar &achy_ 
cardia induced by programmed stimulation. We postulated 
that patients in whom programmed stimukdioo induced 
uniform ventricular tachycardia after procainamide (but ooly 
polymorphic tachycardia in the absence of antiarrhythmic 
drugs) should have evidence of anatomic and electrophysi- 
ologic substrates most commonly see” with reentrant ve”- 
tricular tachycardia. These included previous myocardial 
infarction with extensive left ventricular dysfunction, repro- 
ducible initiation and termination of uniform sustaine,: ven- 
tricular tachycardia by programmed stimulat;o” and abnor- 
malities of the signal-averaged electrocardiogram (ECG) and 
left ventricular endocardial activation typically seen in pa- 
tients with sustainedventriculartachycardia. Inaddition, we 
explored the potential clinical utility of this response. 
Methods 
ias& thk response to pro&amide could not he tested 
(because of allergic history [II = 21 or hypatensio” during 
intravenous infusion [n = II). The indications for electro- 
physiologic study included syncope (n = 221, cardiac arrest 
(n = 36). asymptomatic nonsurtained ventricular tachycar- 
dia (n = 6). sustained uniform ventricular tachycardia (n = 
I I) and miscellaneous conditions MaI tachvcardia. reen- 
Study paticots. We prospectively studied the effects of 
procainamide in 79 consecutive patients in whom pro- 
grammed stimulation in the baseline state induced only 
wlvmoruhic ventricular tachvcardia. I” three additional 
tamed ve”tricular tachycardia. Anatomic diises in thex 
patients included coronary artery disease in 18 (of whom !7 
had had a prior myocardiat iofarctio”). cardiomyopathy in 6, 
valvular disease in 3 and no apparent structural heart disease 
in 8. This was not a consecutive series of patients. Rather, 
we attw-*‘” ‘n %ose pa::icnts in&i to the patieois with ..~.l” .” “,, 
uniform ventricular tachycardia induced after procainamida, 
with respect to the type of heart disease and di preteen- 
tation. 
Pmtocul. Atier giving written iuformed consent, alI pa- 
tients uudewent pro8ranuned stimulation after the anti- 
arrhythmic drugs had heen discontinued for at least 5 half- 
lives. This protocol was approved by the University of 
Pennsylvania Institutional Review Board on September 7, 
1976. 
intracardiac electmgmms. Fmm I to 3 premature e&&n- 
uli were delivered during a” 8-beat drive during at least two 
paced cycle lengths (usualty 6Cil and 400 “is) from at least 
two right ventricular sites. Stimuli were delivered at twice 
diastolic threshold with use of a pulse width of I ms. The end 
point for programmed stimulation wa induction of sustained 
ventricular tachvcardia orcomoletionofthe orotocol withall 
Programmed stimutatk was perfomxd by using previ- 
ously described methods and equipment (7). Briefly, thw to 
five surface ECG leads were recorded simultawouslv with 
tkt supraventricular tachycardia,~atriai flutter and palpita- 
tion; n = 4). Structural heart disease was present in all hut 13 
patients. Fiiy-four patients had coronary artery disease, of 
whom 50 had had a prior myocardial iufarction (~1 month 
before the study). Heart disease in the remaining patients 
included cardiomyopathy in six patients, hypertensive car- 
diovascular disease in three and valvular disease in three. 
Seventy-eight percent of the patients were me”. 
To determine whether procaintide would promote it+ 
duction of uniform ventricular tachycardia in patients with 
no inducible ventricular tachycardia. we studied a control 
group of 35 additional patients who I) had no ve”tricular 
tachvcardia induced bv “mara”““ed stimulation in the ah- 
3 extrastimuli achieving retiktoriness. &udatio” was 
stopped in five patients when repmducihie initiation of long 
(215 compiexes) runs of polymorphic ventricular tachycar- 
dia occurred. The same end point was utilized for pm- 
emmmed stimulation in the baseline state and after enxaiu- 
amide. 
After completion of the baseline stimulation protocol. 
omcaiuamide was administered to a dose of 15 m&z body 
&i&t at a maximal rate of 50 mglmin. follows by H 
maintenance infusion at a rate of 0.11 mgkg per mkt. 
Stimulation was begun S min after the beginning of the 
maintenance infusion. Serum specimens for pmcainamide 
levels were obtained at the conclusion of the stinmlatiou 
se& of antiarrhythn% d&8$, and 2) underwent repeat protocol. 
programmed stimulation atIer administration of pmcaina- Signal-averaged EC& were performed by the method of 
tide. The owoase of this studv was to determine whether Sin 19) in the absewe ofantiarrhythmic drugs within 48 h . . 
unifor”~ ventricular tachycardia induced afwr mainamide of the e<ectrophysiolc& study in Pipatients (61 of 79 study 
resukd from canvexsion of induced ventricular tachycardia patients and 27 of 35 control patients). Analysis was per- 
from a polymotpluc to a uniform pattern or from facilitation formed of IS0 to 200 sinus complexes ushg a 40.Hz high 
of inductiou of new ventricular tachycardia. We reasoned pass filter. Tracings with noise levels >0.6 ,A were rejected. 
that ifuniform ventricular tachvcardia induced afterpmcain- Values for duration of the filtered QRS X14 ms are consid- 
amide was not related to the-polymorphic tachykdia in- wed abnomud. Amplitudes of the last 40 ms of the filtered 
duced in the baseline state. the mevalence of unifor”~ ORS <20 rrV are defined as late potentials. 
tachycardia after pmzaiaami~e in tlk control group would _ Left vekicular endofardial a&ivatio” was mapped dur- 
be similar to that in the patients with polymorphic tachycar- iog sinus rhythm in 22 patients by using methods described 
dia induced at the baseline study. These 35 patients were previously (10.11). 
studied for evaluation of syncope or presyncope (n = 9), Detinitions. The f&wing definitions were used. 
cardiac arrest (n = 8), nansustained ventricular tachycardia Nonsustained venrricular rachycordia = tachycardia last- 
(n = 10) and exercise-induced sustained ventricular tachy- ing at least 3 beats, terminating spontaneously within 30 S, 
cardia (n = 3). Five patients were unde.going postoperative and having a rate >toO beat&in. 
stimulation after subendocardiat resection for recurrent sus- Sustained venrricrdar tmhycardia = tachycardia having a 
rate > 100 beats/min, lasting >30 s or requiring tem&mtion 
by pacing or cardioversion in ~30 s because of loss of 
CO"SCiO"SlRSS. 
Polymorphic venrricular rachycardill = tachycardia hav- 
ine a rate >I00 beats/min. in which the surface ECG 
morphologic changes continuously (no more than 5 consec- 
utive complexes with the sume morphology, recorded in 
three or more leads). If sustained, this arrhythmia freauentiv 
degenerated into ventricular fibrillation. We did not r&n$ 
todifferentiate between polymorphic ventricular tachycardia 
and ventricular libriiiation. 
Uniform veurriculor tarhycardia = tachycardia in which 
the surface ECG configuration recxded in three or more 
leads remains con&w& 
Lore pofential = root-mean-square voltage of the last 
40 ms of the filtered QRS complex <20 PV. 
Eleclrogrom cheracteristics. Eiectrograms are character- 
ized as normal, abnormal or fractionated by at least two of 
three criteria of amplitude, duration and amplitude/duration 
ratio described previously ~10.11): Abnormal electro- 
grams = eiectrograms with an amplitude <3 mV, a duration 
>70 ms or an amplitude/duration ratio <0.046. Fracrionared 
electrograms = electrograms with an amplitude 50.5 mV, a 
duration 8133 ms or an amplitude/duration ratio r0.005. 
Lore eleclrogramr = ekctrograms extending beyond the end 
of the surface QRS complex. Endocardial activation rfme = 
the interval from the earliest local activation to the latest 
local activation. 
Data analysis. Results of continuous variables are ex- 
pressed as the mea” vrduc 2 I SD. Comparison of continu- 
ous variables was performed by using analysis of variance. 
Categoric variables were compared by using contingency 
Figure 1. Example of polymorphic ventricular tacbycar- 
dia. that was induced in the baseline state and became 
uniform after administration of pmcainamide. Top pawI, 
Programmed stinwlation in the control state. At a paced 
cycle length of603 ms with 3 extrastimuli delivered at the 
right ventricular spa, sustained rapid polymor&ic ven- 
tricular tachycardia is induced. Bottom two wets, Pm- 
gnmmed stimulation afleradministrationotpr~amide 
to a serum level of 7.4 mgiliter 0). Fmgrammcd stir&x. 
lion at the right ventricular apex at cycle kogths of W 
and SO ms induces sustained uniform ventricular txhy- 
cardiaof varying CotigUrations with I and 2 extrastimuli. 
Each panel shows surface ECG leads I, aVF and V, and 
intracardiac tracings from the right ventricular outflow 
tract (RVOT) and right ventricular apex (RVN. Tracings 
in the top ~enei also illustrate the His bundle ekctrogram 
@iBE). Time lines are indicated at 100 ms. 
tables. p values < 0.05 were considered statistically signiti- 
cont. 
The signal-averaged ECG was analyzed in 51 of the 64 
study patients and in 21 of the 27 control patients in whom it 
was performed. Results in I3 study patients and 6 control 
patients with bundle branch block or intraventriculer con- 
duction delays al i0 ms were excluded from this analysis. 
ReSUltS 
The 79 study patients by definition had xly polymorphic 
ventricular tachycardia without any uniionn ventricular 
tachycardia induced at the baseline eiectrophysioiogic 
study. The induced polymorphic tachycardia was sustained 
in 38 patients: in the remaining 41, only nonsustained tachy- 
cardia was induced. The cycle length of the induced poly. 
morphic tachycardia usually varied from boat to beat (range 
170 to 230 ms). Induction of the polymorphic tachycardia 
was reproducible (induced ~-2 times) in 67 of the ?I patients 
in whom reproduction of the arrhythmia was attempted. 
Reproduction of the arrhythmia was not attempted in eight 
patients with sustained induced polymorphic tachycardia 
thet required cardioversion. 
Response to prctpmmed stimulation after pmeatnamtde. 
The 79 patients were then classified into three groups BE. 
cording to the response to programmed stimulation after 
Qrocainamide. Group I consisted of 24 patients in whom 
uniform ventricular tachycerdia was induced after procain- 
amide (Fig, 1). The uniform tachycardia was sustained in 18 
patients; in the remaining 6, only nonsustained uniform 
tachycardia wes induced. The mean cycle length of the 
induced uniform tachycardia was 294 * 42 ms. Twelve-lead 
ECGs of spontaneous suslained ventricular tachycardia 
were available in three Grouo L vatients. The confimuation 
of uniform ventricular tach&&a induced after &ain- 
amide did not match that of the spontaneous ventricular 
tachywdia in any of these three. Induction of the uniform 
tachycardia was reproducible in IS of the 18 patients in 
whom repxduction of the arrhythmia was attempted. Re- 
production of the induced ventricular tachycardia was not 
attempted in the remaining six patients btcmse the indxcd 
tachycardia caused loss of consciousness requiring cardio- 
version. The induced sustained ventricular tachycardia was 
tetinated bv overdrive pacing or extmstimuli in IS of 18 
patients. Five of these patients had developed the spontane- 
ous arrhythoda while receiving empiric annarhythmic ther- 
apy (quinidine in three, procainamide in one and tocainide in 
OllC). 
Group 7 c.nsisted d 30 patients in whom induction of 
polymorphic ventticuia tachycadia persisted after procain- 
amide admoxdstration. The induced tachycardias were sus- 
tained in 9 patients; only nonsustained tachywdia was 
induced in the remaining 21. The mode of ventricular tachy- 
cardia induction was onchaoSed in 21 patients after procain- 
amide, whereas induction reqoired one more extrastimulus 
in 7 patients and one less extrastimulus in 2 patients. One 
patient had previously developed spontaneous ventricular 
tachycardis while receiving pmcainamide and lidomine. 
Group 3 consisted of the remaining 25 patients in whom no 
ventricular mchycardia was inducible after pmcainamide 
administmtioo. Three of these patients had experienced 
cardiac arrest while receiving mdnidbx (n = 2) or disown- 
mide (n = I). 
. 
Clbll&Chulo*rbtlesIldtypesOfbeut~~The 
ages of patients were similarforallgmups (Table I). Patients 
in Group 1 were signbicaatly less likely to he female than 
were those in Group 2 or 3 (Table 1). However, when 
patients with coronary disease only were analyzed, there 
was no sign&ant diierence in the distribution of gender 
across the~goups. The pmcainamide levels attained during 
the rlectrophysiologic study in each group were similar 
(Tabie I). in 36 cases, pmc.~inamide levels were obtained 
5 min after the start of the maintenance infusion (just before 
the initiation of programmed sti ulation) and at the end of 
the stimulation protocol. The mean dierence between the 
prcainamide levels before and at&r stimulation in these. 36 
patients was 1.9 &liter (range 0.1 to 3.6). 
Polymorphic ventrkwlar tachycardia was induced io 28% 
of patients by extrastimuli more premature than I80 ms. 
However, it was induced by such an extrasiimulus in only 2 
Group I patients in contrast to 11 Group 2 patients and 8 
Group 3 patients (p = 0.034). The coopliog interval of the 
most premature extrastimulus required to induce pdymor- 
phic ventricular tachycardia was sigoiiicaotly longer for 
Group 1 patients (193.8 2 17.1 ms) thao that for Group 3 
patients (176.8 f 21.2 ms, p = 0.019) but not than that for 
Group 2 patients (184.5 f 21.0 ms). There was no differera 
among the three grwps with respect o the duration or cycle 
length of induced polymor&ic tachycwdias. 
The clinical presentations and types and extent of under- 
lying heart disease differed sigolfwmlly among the three 
goups (Tables 2 and 3). The prevalence of coronary artery 
disease was sbgiliantly higher in Group 1 patients than i  
either Groop 2 or Group3 patients. Tweoty-three(% 
Group I patients had coronary artery aisease compared with 
only 63% of Group 2 p&MS and only 489% of Gmup 3 
patients @ = 0X13). Similarly, patients in Group I were 
more likely to have experienced a previous myoxdial 
infarction (96% vs. 53% of patients in Group 2 and 48% of 
patients in Group 3, p = 0.00s). 
Patients in Group I differed signi&ntly from those in 
Groups 2 and 3 with regard to variables of left ventricular 
anatomy and function. Forty-six percent of Group I patients 
had a I& ventricoku aneurysm compared with 13% and 0% 
of Gmup 2 and 3 patients, respectively @ = O.OW2). The 
mean left ventricular ejectkm fraction was also signiftcantly 
lower in Group 1 patients than in patients in either of the 
other two 8roops (p = 0.019) (Table 2). These differences in 
Tabk 3. Clinical Presentation f the Study Patients 
Tabk 1. Results of Signal-Averaged Electrocardiography b tbe Study Patiects 
ORS 
left ventricular function were even more striking when only 
patients with coronary artery disease were compared. Forty- 
eight oercent of Gram 1 oatients with coronarv disease had 
a left’ ventricular at&-&m compared with holy 21% of 
Gmuo 2 and 0% of Grotto 3 oatients (D = 0.00~7). The mean 
ejeetibn fraction in Group I batieds with coronary disease 
was 31% versus 52% and 46% in Groups 2 and 3, respec- 
tively (p = 0.0048). 
Eight of the 1 I patients who had presented with sustained 
monomorphic ventricular tachycardia were in Group 1. Two 
of the remaining three patients who had presented with 
monomorphic sustained ventricular tachycardia (one in 
Group 2 and one in Group 3) bad ooncomnary disease; one 
had no structural heart disease, one had undergone antic 
valve replacement for aortic regurgitation I week earlier. A 
third patient had presented with monomorphic ventricular 
tachy&dia in the acute phase of a tint m&xdial iofarc- 
tion. He had no ventricular tachvcardia induced before or 
atIer procainamide. All eight p&ients with spontaneous 
monomorphic sustained ventricular tachycardia in Group 1 
had coronary disease with previous myoardial infarction 
(Table 3). 
Siglucnveraqed eleetreardicgnpby and eleetmphyao- 
bgie and mapping stodiw. The characteristics of the sigoal- 
averaged electrocardiogram were also different for Group 1 
thao for Groaps 2 and 3 (Table 4). The wan Altered QRS 
duration in Group I (118 ms) was significantly longer than 
the fillered QRS duration in either Group 2 (106 ms) or 
Gmup 3 (101 ms) (p = 0.04). Fifty-six percent of the patients 
in Group 1 had an abnormal (> 114 ms) filtered QRS duration 
compared with only 25% and 20% in Groups 2 and 3, 
respectively (p = 0.06). The amplitude of the final 40 ms of 
the filtered QRS complex did not diier sigobicantly among 
the three groups of patients. However, late potentials were 
found significantly more often in Group I (56%) than in 
Group 2 (35%) or Group 3 (13%) (p = 0.04). 
Patients in Grow 2 (wrsistent iodttcible wlvmomhic 
ventricular tachyc&dia) could not be diierentiated t&n 
those in Gmuo 3 (no inducible ventricular taciwcardia after 
procain2midej wiih respect to presence, type Or extent of 
underlying heart disease, or any of the signal-averaged EC0 
variables. However, Group 2 patients did diier significaotly 
from Group 3 patients with regard to the oumber of venttic- 
ttlar extrastimuli required to induce polymorphic ventricular 
tachycaniia in the absence of procainamide @ = 0.035): 
polymorphic ventticolar tachycardia was induced by double 
extrastimuli in 53% of Group 2 patieots but in only 20% of 
Group 3 patients @O% of Group 3 patients reqoired 3 
extrastimuli to induce polymorphic ventricular tachywdia). 
Induction of polymorphic ventrictdar tachycardia in Group 1 
was imilar to that in Group 2: 45% of Group I patients 
required 2 extrastimuli to induce polymorphic ventricular 
tachycafdia. Polymorphic ven~ricolar tachywdia was in- 
duced by 1 extmstimoltts in ooe Group I patient. 
To analyze the results of the left ventricular wtivation 
maps WC combined Gmops 2 and 3 because the patients in 
these two groups were so similar in all other variables, and 
because of the relatively smell number of patients in whom 
left ventricular activation maps were performed. Seven 
patients in Group I ooderweot mapping compared with 15 
patients in combined Gmops 2 attd 3. Ihc number of sites 
mapped was similar for each (Table 5). ‘IIe percent of sites 
with abnomtal electmgrams, fractionated electrogtams and 
late electmgrams was greater for the ~&cots developing 
uniform venlricul~ tachycardia atIer procaioamide, but the 
difference achieved statistical significance only for the per- 
cent of rites with fractionated electmgrams because of the 
small number of patients analyzed (Table 5). The cndocw- 
dial activation time was slightly longer for Group I. and the 
domtioo of the longest local electrograttt was signilicatttly 
greater for Group 1 patients (Table 5). 
The mean pmcainamide level achieved during the clee- 
trophysiologic study in the control group without inducible 
ventdcular tachycardia at the baseline study was 9.7 mg/iiter 
(p = NS vs. Group I). Programmed stimulation after pro- 
cainamide administration in this group revealed inducible 
ventriculartachyahmias in 5 ofthe 35 patients (ventric- 
ular fibrillation or flutter in 2 patients and monomorphic 
tachycwdii in 3). The monomorphic ventricular tachycar- 
dias included bundle branch reentry in one patient with 
dilated cardiomyopathy and uniform ventricular tachycwdia 
having a cycle length of 400 and 320 ms, respectively, in the 
remaining two patients with coronary disease. One of these 
patients was undergoing programmed stimulation ior evalu- 
ation of the results of subendocardial resecttoo for uniform 
ver~tricular tachycardia. The other patient was undergoing 
an ekctrophysiologic study to evaluate 1~1 episode of sus- 
tained ventricular tachycardia that precipitated cardiac ar- 
rest during empiric therapy with encainide. The rate of 
inducible unifono ventricular tachycardia after procain- 
amide in patients with coronary disease and polymorphic 
ventricular tachycardia induced at the baseline sttiy (23 of 
54) is sigoifc~ntly higher tkn this rate in patients with no 
ventricular tachycardia induced at the baseline study (2 of 
18). The mea” left ventricular ejection fi.c&n in this gmup 
of 34% was similar to the mean ejection frac!ion of Group 1 
but signiIicantly less than that of Group 2 or 3 (Table 2). The 
sipnai-averaged ECG variables in the control patients were 
&tiler to those in Groups 2 and 3 and significantly ditferent 
horn those of Group I an average. That is. the mean filtered 
QRS duration was only 100.9 ms, and only 2 of 21 patients 
had an abwmtally pmlcnged QRS duration. Late potentials 
were present in only 3 of the 24 control patients (without 
inducible ventricular tachycardia at the baseline study) for 
whom the signal-averaged ECG could be interpreted. 
Treatmat and fdlow-nap. In Group I patients, treatment 
vm iodividualized on the basis of clinical presentation and 
the unifom~ tachycardias induced in the presence of procain- 
amide (sod in many cases, other antiarrhythmic agents, too). 
The monomorphic sustained ventriculartachycardia induced 
in the presence of procainamide formed the basis for per- 
forming activation mapping-guided subendocardial resection 
in fo”r patients (two had presented with cardiac arrest ad 
two had presented with stable monomorphic sustained ven- 
tricular tachycardia). After surgery, pmgrammed srimula- 
lion faded to induce uniform and polymorphic ventricular 
duced ventricular tachycardii. Two of these three also 
received an implant&k cardioverterdefibriilator (two had 
preqented with sustained uniform ventricular achy&k, 
and one with cardii arrest). Two patients underwent myo- 
cardial revascularization (one had presented with cardiac 
arrest. the other with sustaimd ventricular tachycardia and 
angina). The last live patients in this group were discharged 
with no antiarrhythmic therapy. After a “teaa foRoow-“p 
interval of 40 months (mope 17 to 87). two of these lrve 
patients experienced sudden cardii death. One patient 
originally presented with sustained ventricular taehycardia. 
the other with a cardiac arrest; both were discbarged with 
ven!ricular tachycardia persistently inducibie with amk- 
darone. The five patients discharged with no atttiar~hytbmic 
therapy (because of infrequent, nonlife-threatening arrbylh- 
miss) 81 alive and well. Two patients were lost to follow-up. 
Group 2 patienrs with p~lymwpbic ventricular taehycar. 
die persistently inducible after p&de were treated 
primarily on the bads of their origkl clinical preseotatiw. 
Coronary artery bypass grafting was performed in fozz 
patients (all had presented with cardiac arrest). Implantation 
of a cardiovenerdelibrillator was performed in seven pa 
tients, six of whom had presented with cardiac arrest. and 
one with syncope. Thkteett patients received pltamzol~ 
atttiarrhythmic therapy. In five patierds phamtacologic ther- 
apy was given as a” adjunct to an implanted caniiwerter- 
defibrillator. In the other eight patients pharmafolagic tber- 
spy alone wet adzkistzed (four had presented with cardiac 
arrest, three with syocopz and o”e with atrial titter with 
aberrant intraveatricular cwduction). Eleven patients were 
discharged with no aotiarrhytic therapy: three had pre- 
sented with syncope, hve witlt asymptomatic no”sustaioed 
ventricular tachycardii and one each with s”prave”tricular 
tachycardia, cardiac awest and v.wricular tachycardia while 
receiving antiarthythmic therapy. After a “tea” follow-up 
period of 37 months (range 2 to I1 I months. we patient lost 
to follow-up). one patient who had been treated by myocar- 
dial revaxularizatio” expetieoeed a rearrest cardiac arrest 
from which he was resuscitated. 
Group 3porienfs (with polymorphic ve”tricular tachycar- 
dia “a longer inducible after pnxainamide) were treated an 
the basis of clinical presentation and results of elecbophys- 
iologic studies. One patient *ho had presented with vcotric- 
“lar tachycardia early after acute myocardial infarcticm 
tachycardia in all four cases. Pharmacologic antiarrhythmic underwent coronary attery bypass gr&ittg and was given 
therapy rendered ventricular tachycardia (both uniform and procainamide. Nine patients were given ~b~acologic ad- 
polyinot’pbic) noninducible in two patients, and they were &rhythmic therapy ihat eliminated indkible polymot@ic 
discbarged on these regimens. Phamtacologic therapy re- ventticular tachwrdia (four presented with cardiac arrest, 
staled in persistently inducible uniform hut hemodynami- three with sy&pe, one with palpitation and one with 
tally stable sustained ventriculat tachywdia in eight pa- uniform ventricular tachycardia early after aortic valve 
tients, and they were discharged on these regimens. replacement). The remaining I5 patients were given no 
Sustained unifon” ventricular tachycardia remained induc- antisrrhythmic therapy. After a mean follow-up period Of 41 
ible and he”mdynamicaUy unstable after multiple drug trials months (range 3 to s4), three patients had experienced 
in three patients. Au were discharged on the pharmacologic rec”rrettt car&a arrest. all of whom were discharged with- 
r&men that made induction most “diBc”lt” (rewired the o”t inducible ventricular tachycardia on treatment with 
m&t extrastimuli) and caused the greatest sl&& of in- prwainamide. 
Discussion the induced polymorphic ventricular tachycardia nd to alter 
This study has demonstrated that cowrsion of inducible 
c&morphic ventricular tachycardia into inducible uniform . . 
ventricular tachycardia after procainamide is not rare: ap- 
oroaimatelv 30% (24 of the 79) oatients studied exhibited this . 
nommlities similar to those found in patients with spontane- 
response. Our analysis sugg.&s that this response OCCIUS 
ous and inducible uniform ventricular tachycardia (12). 
almost exclusively in patients with coronary artery disease 
and orior mvocardial infarction with sirmiticaot ventricular 
Finally, subendocardial resection, guided by activation map 
dysf;nction who have experienced sp&meous sustained 
~entri~ult~ tachyarrhythmias. The majority of these patients 
exhibited abno..nalities of the signal-averaged ECG typical 
of those of patients with spontaneous monomorphic ventric- 
ular tachycardia, that is, abnomnlly prolonged filtered QU8 
durations and a high prevalence of “late potentials.” Par- 
thermore, the left ventricular sinus rhythm maps in Group 1 
showed ~&LX of extensive endowdial conduction ab- 
characteristics of a “latent” reentrant circuit responsible for 
the uniform ventricular tachycardia, permitting its expres- 
sion in response to programmed stimulation. To examine the 
ooifom~ Ad polymorphic ve&icolar tachy&dia were no 
latteroassibilitv. we evaluated the ~esconse to procainamide 
in tbebatients who had no ventricular i chyc&a induced in 
longer inducible in these four patients. Facilitation of bundle 
the baseline state. Oolv 6% (2 of 35) of patients in this moop 
branch reentry, 88 we observed in one patient, has been 
had inducible uniform~ent~cular tach&dia after p&xii- 
amide administration. This observation suggests that the 
latter mechanism may have accounted for some of the 
responses observed in Group I patients but was probably not 
resoonsible for most of these responses or the rate nf 
inducible uniform ventricular tach&rdia in the control 
erouo would have been closer to the 32% observed in the 
I . 
study group. Furthem~ore, four Group 1 patients underwent 
activation mapping-guided subendocadial resection for their 
monomorohic veotriculwtachvcardia. Postoperatively, both 
ping of the induced uniform tachycardia in four patients, described previously, and appears to result prbnarily from 
resulted in cure of both the uniform and the polymorphic slowing of conduction in the His-Porkinje system after 
tachycardias. Thus, the patients developing inducible uni- pro&amide (13). 
form ventricular tachycardia atler procainamide had the The characteristics of patients with persistent inducible 
typical substrates seen in patients with reentrant sustained polymorphic ventricular taehycardia verses those without 
ventricular tachycardia. inducible tachycardia after procabmmide did not ditTer. 
Inducible polymorphic tachycardia was converted to uni- Patients in these tsvo groups (Groups 2 and 3) were similar 
fom, ventricular tachycardia after pmcainamide in 31% (II with regard to clinical presentation and type and extent of 
of 36) of patients undergoing evaluation for a cardiac arrest, underlying heart disease as reflected by left ventricular 
in 14% (3 of 22) of oatients evaluated for wncope and in 72% ejection fraction. The greater likelihood of Group 3 patients 
(8 of il) of ‘ti&e evaluated for sponia”e& sustained 
useful in eval&iog the clinical significance of’indwed 
polymorphic ventricular tachycardia and in guiding therapy. 
ventricular tachvcardia. We believe that this reswnse is 
This is best exemplified by the four patients who underwent 
activation map-guided surgical resection, resulting in cure of 
both inducible uniform and polymorphic ventricular tachy. 
cardia. However, the clinical implications of failure of in- 
duced tachycardia to become uniform are difficult to deter- 
mine because treatment was necessarily individualized. 
Clearly, abolition of inducible polymorphic ventricular 
tachycardia by procaioamide (the Gioop 3 response) cannot 
be taken as a favorable response because three of four 
patients treated pharmacologicaUy who had presented with 
cardiac arrest experienced rworrent cardiac arrest. This rate 
of recurrence is significantly higher !ban that observed in 
Group I patients (I of II). 
origin of the ventricular tachycardiaor effects at the site of 
10 require 3 extrastim& to induce polynorphic ventricular 
stimulatioo or intervening tissue, or both. 
tachvcardia is compatible with dw effecects at the sits of 
Our observations extend those of Horowitz et rd. (6), who 
suggested that inducible polymmpbic ventricular tachycar- 
dia occurs in home cases on the basis of reentry witbin the 
myocardium. Our patients had no evidence of a prolonged 
QT interval ivhen studied in the absence of antiarrhythmic 
drugs and none had evidence of a long QT interval after 
administration of intravenous procainamide. Although 
Horowitz et al. (6) termed their patients’ arrhythmia “tor- 
sade de pointes,” they recognized that this rhythm was not 
the classic “torsade” described by Dessertennes. Because 
recent information suggesting that torsade de pointes in 
association with a prolonged QT interval is due to early 
afterdepolarizations, we believe that the arrhythmias ob- 
served in the current study and that of Horowitz et al. are 
more properly termed “polymorphic ventricular tachycar- 
dia.” The ability to reproducibly initiate and terminate the 
Mecbantsm of tacbyea& cenversIon. The mechanism 
underlying the apparent conversion of polymorphic vent+ 
ular tachycardia to the uniform tachycardias is less clear 
from this study. It seems most likely that the polymorphic majority of unifom~ tachycerdias by programmed stimula- 
venbicslar tachycardias induced in the baseline state in tion is most consistent with a reentrant mechanism. Atso 
Group I patients were slowed by procainamide, permitting consistent with reentry is the observation of abnormalities of 
expression of a uniform tachycardia contigoration after endowdial acttvation: slow local conduction and delayed 
procalnamide. It is also possible that the effect of pmcain- global activation revealed by the sinus rhythm maps. Al- 
amide administration in the Group 1 patients was to abolish though the relatively small number of patients who under- 
went mapping precluded attaining statistical significance for 
most of the observations, there was considerable consis- 
tency in the measurements. All the variables measured were 
more abnormal in patients with inducible uniform ventricular 
tachycardia. In addition, the percent of abnormal, fraction- 
ated and late electrograms were very similar to those ob- 
served in patients with spontaneous and inducible uniform 
sustained ventricular tachycardia in other studies (12). 
Hunt and Ross (14) recently reported observations imilar 
to ours in 8 dog model of myocardial infarction. After 
observing conversion of polymorphic induced ventricular 
tachycardia to uniform (induced) ventricular tachycardia 
after pmcainamide in six of nine anlmals, they suggested that 
this effect represented a “pmarrhythmic” manifestation of 
procainamide. We hesitate to draw a similar conclusion from 
our data because the spontaneous arrhythmias in the major- 
ity of our patients had developed in the absence of anti- 
arrhythmic drugs. Of the 24 patients who had inducible 
uniform ventricular tachycardia after pmcainamide adminis- 
tration, only 5 had had their prior spontaneous arrhythmias 
while receiving antiarrhythmic drugs (2 patients with cardiac 
arrest and 1 patient with syncope during treatment with 
quinidine, and 2 patients who had sustained monomorphic 
ventricular tachycardia while receiving tocainide or prcain- 
amide, respectively). In none of these caw did the sponta- 
neous event appear to be related to a drug-induced long QT 
syndrome. while these patients’ spontaneous arrhythmias 
did not occur in the presence of pmcainamide, we believe 
that it is premature to conclude that the observed effects in 
the electmphysiology laboratory represent “pmarrhyth- 
mia.” However, it is possible that if our patients developing 
uniform ventricular tachycardia after procninamidc wnre 
discharged on treatment with this agent, they might have an 
increased frequency of spontaneous episodes or some other 
possible “pmarrhythmic” effect. 
Au et al. (IS) also observed the induction of uniform 
ventricular tachycardia after administration of type IA 
agents in 2 of I4 patients without inducible tacbycardia in the 
baseline state and in 2 of 10 patients with nonsustained 
polymorphic ventricular tachycardia at the baseline study. 
They also considered these findings to represent “pro- 
arrhythmic” responses. However, none of their patients had 
previously experienced spontancaus symptomatic arrhyth- 
miss. We hesitate to classify such respanxs as pmarrhyth- 
mic in the absence of any clinical correlation. 
the spontaneous ventricular tachycardia. Although the mor- 
phclogy of sostzined ventricular tachywdia induced after 
pmcainamide did not match that observed spontaneously in 
3 cases. this is oat unusual, as anttiythmic agents often 
alter the morphology ofspaotane~us and indueedvearicular 
tachycxdia. It is also important to remember that the patient 
population studied here is heterogeneous. Altlwugb the 
majority had coronary artery disease, espwiaUy among the 
patients that developed uniform venhiculartachycardiaafter 
urocainamide, it is diUicult to be certain of the si!&cance of 
ihe procainamide response in patients with &ischemic 
heart disease. 
Clinical impt~. In summary, our obwwatbns aug- 
gest that in patients undergoing electmphysidogic study for 
evaluation of clinical ventricular tachyarrhytbmias, when 
only polymorphic ventricular tachycardia is induced at the 
baseline study. repeat study in the presence of an anti- 
arrhythmic drug such as pmcainamide may prove useful in 
guiding antiarrhythmic therapy. This response is especially 
likely to occur in patients with coronary artery disease and 
prior myocardial infarction and may facilitate induction of 
bundle branch reentrant achycardia. Our observations ug- 
gest that abolition of inducible polymorphic ventricular 
tachycardia by prcama&te is not a clinically relevant or 
useful response. 
Limi(sttom of the sh&. There are several limitations to 
this study. Because we do not have ECG documentation at 
the c&of cardiac arrest or apisodesof syncope. we cannot 
be certain tbzt the uniform tachycardia induced after pro- 
cainamide in patients who were evaluated after syncope or 
cardiac arrest was responsible for the spontaneous arrhyth- 
miss. In addition. we don’t have ver%cation in all cases of 
the morphology on ILlead electrocardiograms of spontane- 
ous sustained ventricuIar tachyctiia, and therefore. cannot 
be certain that the morphology of uniform ventricular tachy- 
cardia indwexi after procainamide was the same as that of 

